Search

everythinglearnresearchcommunity

for

Search:↓

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Dupilumab treatment reduces Th2-related markers and helps hair growth in alopecia areata, showing Th2's role in the condition.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

Promising cancer treatments were found, but the manufacturer closed.

A new patch can deliver stable antibodies over time for potential HIV treatment.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

CD2 might be a new treatment target for patchy alopecia areata.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Baricitinib is effective for Alopecia Areata but requires careful patient history evaluation.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

JAK inhibitors might help treat alopecia areata.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Sonidegib is effective and safe for treating advanced basal cell carcinoma, but biopsies are needed to confirm tumor clearance.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Bimekizumab effectively treated a man's chronic beard hair loss.

Calancardin B may help reduce inflammation in immune cells.

Betulinic acid can help treat hepatitis C by stopping virus replication.

Thymosin beta 4 protects cells from damage by blocking a harmful microRNA and boosting a protective gene.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.